Related Experiment Videos
Adenovirus-based genetic vaccines for biodefense
Julie L Boyer1, Gary Kobinger, James M Wilson
1Department of Genetic Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Human Gene Therapy
|March 12, 2005
Summary
Adenovirus (Ad) vectors elicit strong host responses, making them ideal vaccine platforms against bioterror pathogens. This review highlights their potential and development for biodefense applications.
Area of Science:
- Biotechnology
- Vaccinology
- Infectious Disease
Background:
- Adenovirus (Ad) gene transfer vectors elicit robust host immune responses.
- These responses can be harnessed for vaccine development against dangerous pathogens.
- Ad vectors offer a promising platform technology for biodefense.
Purpose of the Study:
- To review the use of Ad vectors as vaccine platforms against bioterror pathogens.
- To highlight the advantages of Ad vectors for biodefense applications.
- To discuss strategies for enhancing Ad vector vaccine efficacy.
Main Methods:
- Review of existing literature on Ad vectors and bioterror pathogens.
- Analysis of host responses to Ad gene transfer vectors.
- Case studies from laboratory research on Ad-based vaccines.
Main Results:
- Ad vectors induce potent immune responses suitable for vaccines.
- Specific Ad vectors (E1-, E3-) are well-suited for vaccine platforms.
- Laboratory examples demonstrate Ad vector efficacy against bioterror agents.
Conclusions:
- Ad-based vectors are a viable platform technology for anti-bioterror vaccines.
- Further development can enhance the efficacy of Ad vector vaccines.
- Ad vectors represent a critical tool in biodefense strategies.